Literature DB >> 25959528

Cholesterol gallstones and bile host diverse bacterial communities with potential to promote the formation of gallstones.

Yuhong Peng1, Yang Yang1, Yongkang Liu2, Yuanyang Nie1, Peilun Xu1, Baixue Xia1, Fuzhou Tian3, Qun Sun4.   

Abstract

The prevalence of cholesterol gallstones has increased in recent years. Bacterial infection correlates with the formation of gallstones. We studied the composition and function of bacterial communities in cholesterol gallstones and bile from 22 cholesterol gallstone patients using culture-dependent and culture-independent methods. Altogether fourteen and eight bacterial genera were detected in cholesterol gallstones and bile, respectively. Pseudomonas spp. were the dominant bacteria in both cholesterol gallstones and bile. As judged by diversity indices, hierarchical clustering and principal component analysis, the bacterial communities in gallstones were different from those in bile. The gallstone microbiome was considered more stable than that of bile. The different microbial communities may be partially explained by differences in their habitats. We found that 30% of the culturable strains from cholesterol gallstones secreted β-glucuronidase and phospholipase A2. Pseudomonas aeruginosa strains showed the highest β-glucuronidase activity and produced the highest concentration of phospholipase A2, indicating that Ps. aeruginosa may be a major agent in the formation of cholesterol gallstones.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial community; Bile; Cholesterol gallstones; PCR-DGGE; Phospholipase A2; β-Glucuronidase

Mesh:

Substances:

Year:  2015        PMID: 25959528     DOI: 10.1016/j.micpath.2015.05.002

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation.

Authors:  Alison L Van Dyke; Troy J Kemp; Amanda F Corbel; Bin Zhu; Yu-Tang Gao; Bing-Sheng Wang; Asif Rashid; Ming-Chang Shen; Allan Hildesheim; Ann W Hsing; Ligia A Pinto; Jill Koshiol
Journal:  Ann Epidemiol       Date:  2016-08-31       Impact factor: 3.797

2.  Proton pump inhibitor is a risk factor for recurrence of common bile duct stones after endoscopic sphincterotomy - propensity score matching analysis.

Authors:  Nobuhiko Fukuba; Shunji Ishihara; Hiroki Sonoyama; Noritsugu Yamashita; Masahito Aimi; Yoshiyuki Mishima; Tsuyoshi Mishiro; Hiroshi Tobita; Koutarou Shibagaki; Naoki Oshima; Ichiro Moriyama; Kousaku Kawashima; Tatsuya Miyake; Norihisa Ishimura; Shuichi Sato; Yoshikazu Kinoshita
Journal:  Endosc Int Open       Date:  2017-04

Review 3.  Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases.

Authors:  Cecilia Binda; Giulia Gibiino; Chiara Coluccio; Monica Sbrancia; Elton Dajti; Emanuele Sinagra; Gabriele Capurso; Vittorio Sambri; Alessandro Cucchetti; Giorgio Ercolani; Carlo Fabbri
Journal:  Microorganisms       Date:  2022-01-28

4.  Prevention of gallstones by Lidan Granule: Insight into underlying mechanisms using a guinea pig model.

Authors:  Xiao Wu; Xiaoqiang Liang; Yijie DU; Yan Zhang; Meng Yang; Weiyi Gong; Baojun Liu; Jingcheng Dong; Ningxia Zhang; Hongying Zhang
Journal:  Biomed Rep       Date:  2016-05-06

5.  Biliary Microbiota, Gallstone Disease and Infection with Opisthorchis felineus.

Authors:  Irina V Saltykova; Vjacheslav A Petrov; Maria D Logacheva; Polina G Ivanova; Nikolay V Merzlikin; Alexey E Sazonov; Ludmila M Ogorodova; Paul J Brindley
Journal:  PLoS Negl Trop Dis       Date:  2016-07-22

6.  Proteobacteria Acts as a Pathogenic Risk-Factor for Chronic Abdominal Pain and Diarrhea in Post-Cholecystectomy Syndrome Patients: A Gut Microbiome Metabolomics Study.

Authors:  Zuochang Kang; Mingliang Lu; Mingyuan Jiang; Di Zhou; Hua Huang
Journal:  Med Sci Monit       Date:  2019-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.